These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2109027)
1. [Enhanced cytotoxicity of antineoplastics by interferon]. Yoneda K; Yamamoto T; Osaki T Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):77-84. PubMed ID: 2109027 [TBL] [Abstract][Full Text] [Related]
2. [Potentiation of the cytotoxic effects of anticancer drugs on human genitourinary neoplastic cells by recombinant gamma-interferon]. Yamamoto S; Tanaka H; Namba M Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):699-705. PubMed ID: 3103539 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo. Sayers TJ; Wiltrout TA; McCormick K; Husted C; Wiltrout RH Cancer Res; 1990 Sep; 50(17):5414-20. PubMed ID: 2117482 [TBL] [Abstract][Full Text] [Related]
5. Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells. Schiller JH; Bushmeyer SM; Ruzicka FJ; Princler GL; Faltynek CR; Borden EC Cancer Res; 1990 Jan; 50(1):26-31. PubMed ID: 2136700 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes. Utsugi T; Sone S J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797 [TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Lindner DJ; Borden EC; Kalvakolanu DV Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768 [TBL] [Abstract][Full Text] [Related]
8. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells. Schaber JD; Fang H; Xu J; Grimley PM; Rui H Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833 [TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma is cytotoxic for normal mouse fibroblasts: enhancement by tumor necrosis factor and interleukin 1. Dijkmans R; Decock B; Heremans H; Van Damme J; Billiau A Lymphokine Res; 1989; 8(1):25-34. PubMed ID: 2497277 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth by interferon-gamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. Aune TM; Pogue SL J Clin Invest; 1989 Sep; 84(3):863-75. PubMed ID: 2503544 [TBL] [Abstract][Full Text] [Related]
11. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters. Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715 [TBL] [Abstract][Full Text] [Related]
12. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro. Broxmeyer HE; Cooper S; Rubin BY; Taylor MW J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752 [TBL] [Abstract][Full Text] [Related]
13. Synergistic cytotoxic effects of tumor necrosis factor, interferon-gamma and tamoxifen on breast cancer cell lines. Matsuo S; Takano S; Yamashita J; Ogawa M Anticancer Res; 1992; 12(5):1575-9. PubMed ID: 1444224 [TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice. Heston WD; Fleischmann J; Tackett RE; Ratliff TL Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546 [TBL] [Abstract][Full Text] [Related]
15. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis. Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427 [TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro growth suppression of human glioblastoma cultures treated with the combination of recombinant fibroblast and immune interferons. Vita JR; Edwalds GM; Gorey T; Housepian EM; Fetell MR; Guarini L; Langer JA; Fisher PB Anticancer Res; 1988; 8(3):297-302. PubMed ID: 2839097 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma. Gomi K; Morimoto M; Nakamizo N Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841 [TBL] [Abstract][Full Text] [Related]
18. [Basic study on human interferon-beta: Part II. Anticellular effect]. Kanamori T; Tobita M; Horisawa Y; Nobuhara M Gan To Kagaku Ryoho; 1986 Jun; 13(6):2105-10. PubMed ID: 3717958 [TBL] [Abstract][Full Text] [Related]
19. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines. Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249 [TBL] [Abstract][Full Text] [Related]
20. [The effects of IFN-gamma on the antitumor abilities of immunocytes and chemotherapeutic agents]. Gu Q; Zhu Z; Yin H Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):89-91. PubMed ID: 10374484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]